Form D Explorer
Oncobiomix Inc. · CIK 1998501

Report a data issueCitable research briefCompare issuerPrivate research collection

Oncobiomix Inc.

CIK 1998501 · Corporation · Inc. DELAWARE · San Antonio, Texas · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $1,000,000 in the Sep 2, 2025 filing and $2,500,000 in the Sep 16, 2026 filing. The two records may concern different offerings. Amendments account for 2 of the 3 filings stored from Sep 2, 2025 to Sep 16, 2026.

Filings
3
Original notices
1
Amendments
2
Activity
Sep 2, 2025
through Sep 16, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldSep 2, 2025 · D/ASep 16, 2026 · DLater minus earlier
Reported offering amount$1,000,000$2,500,000$1,500,000
Reported amount sold$500,000$100,000$-400,000
Reported investor count—1—
Reported minimum investment$0$0$0

Earlier SEC source: 0001998501-25-000003 · Later SEC source: 0001998501-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Sep 16, 2026

Reported offering amount
$2,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$100,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)